IGKC and triple-negative breast carcinoma: These results are basically in line with the findings of our present retrospective immunohistochemical study which included 107 patients with early triple-negative breast cancer, from whom 79 received an adjuvant chemotherapy, showing a trend for a higher IgκC expression being associated with a better clinical outcome.